Published 17:18 IST, July 11th 2020
Biocon’s drug Itolizumab gets DCGI Nod for treatment of moderate to severe COVID patients
Biocon's breakthrough drug Itolizumab is one of the first biologic therapy drugs to be approved for the treatment of COVID patients across the world
null | Image:
self
Advertisement
17:12 IST, July 11th 2020